ArticleCureus2026
Paradoxical Cervical Lymphadenitis During Anti-tubercular Therapy in an Immunocompetent Young Female: A Diagnostic Pitfall.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A paradoxical reaction (PR) in tuberculosis (TB) is defined as clinical and/or radiological worsening of pre-existing tuberculous lesions or the appearance of new lesions during appropriate anti-tubercular therapy (ATT), despite initial improvement and in the absence of treatment failure, drug resistance, poor adherence, or superinfection. Although more commonly described in HIV-infected or disseminated TB cases, PR can also occur in immunocompetent individuals and may be misinterpreted as disease progression. We report a case of a 19-year-old immunocompetent female receiving standard first-line ATT for sputum-positive pulmonary TB who developed progressive, painless right cervical lymphadenopathy two months after initiation of therapy. Ultrasonography revealed a large necrotic cervical mass suggestive of a tubercular abscess. Repeated ultrasound-guided fine needle aspiration cytology was inconclusive. Given the absence of systemic symptoms, treatment adherence, and lack of evidence of drug resistance, a diagnosis of PR was considered. In conclusion, recognition of PR is essential to prevent unnecessary modification of ATT, escalation to second-line therapy, or invasive procedures. Clinicians should maintain a high index of suspicion for PR in compliant patients presenting with new or enlarging lesions during the early months of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.